Ergoteles LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$156,000
-84.8%
24,149
-89.3%
0.01%
-83.9%
Q2 2022$1,029,000
+113.0%
224,700
+564.8%
0.03%
+63.2%
Q4 2021$483,00033,8000.02%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 290,501$2,513,0001.83%
Knoll Capital Management, LLC 20,000$173,0000.11%
Private Portfolio Partners LLC 42,250$365,4630.09%
Rossmore Private Capital 40,661$352,0000.06%
OCCUDO QUANTITATIVE STRATEGIES LP 54,233$469,0000.04%
Cubist Systematic Strategies, LLC 241,892$2,092,0000.02%
TWO SIGMA ADVISERS, LP 662,000$5,726,0000.02%
TWO SIGMA INVESTMENTS, LP 550,956$4,766,0000.01%
Jump Financial, LLC 34,800$301,0000.01%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 264,824$2,291,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders